POM-V Prescription Required

Equip T Suspension for Injection

Active ingredient: Clostridium tetani

Form

Injection

Species

Horses

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5232

What it's used for

Onset of immunity: within 2 weeks of completion of the primary course Duration of immunity: 3 years.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Clostridium tetani

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Equip T Suspension for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: within 2 weeks of completion of the primary course
Duration of immunity: 3 years.

Administration: Equip T should be shaken thoroughly before use and administered
by deep intramuscular injection.
Primary vaccination
Two injections of 2 ml with an interval of 4-6 weeks between them.
Booster vaccination
One dose 36 months after the primary course, repeated at intervals of up to 36
months.

None.

Horses.
Rare
(1 to 10 animals / 10,000 animals
treated):
Injection site swelling
1,3
Stiffness
Elevated temperature
1,2
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Injection site pain
Hypersensitivity reaction
1
This condition normally resolves by the day following vaccination.
Mild, transient, typically 9-12 hours post vaccination.
Local, small (10-20 mm in diameter), soft, non-painful.
In the event of an allergic or anaphylactic reaction, immediate treatment should be
given with a soluble glucocorticoid intravenously or adrenalin intramuscularly.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See the package leaflet for respective contact details.

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
The efficacy of active immunisation of young foals against equine influenza will be
influenced by the level of maternally derived antibodies. This will vary between
individuals due to a number of factors, e.g. the immune status of the dam; adequacy
of colostral intake by the foal etc. The vaccine should not be used in foals below 5
months of age, and foals should not be vaccinated until maternally derived
antibodies have fallen below protective levels.
In any animal population there may be a small number of individuals which fail to
respond fully to vaccination. Successful vaccination depends upon correct storage
and administration of the vaccine and the ability of the animal to respond. This can
be influenced by such factors as genetic constitution, intercurrent infection, age,
nutritional status, concurrent drug therapy and stress.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
The product should be administered by respecting appropriate (aseptic) injection
technique.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.

Store in a refrigerator (2 C - 8 C).
Protect from light.
Do not freeze.
Keep the container in the outer carton.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.